Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Mimicry of Protein Function with Cell-Penetrating Peptides

Johansson, H. J., Andaloussi, S. E., & Langel, Ü. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_17 · Cited by 22

Differential activity of conditional MYC and its variant MYC-S in human mortal fibroblasts

Hirst, S. K., & Grandori, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203904 · Cited by 22

LINC00460/miR-186-3p/MYC feedback loop facilitates colorectal cancer immune escape by enhancing CD47 and PD-L1 expressions

Luo, Q., Shen, F., Zhao, S., Dong, L., Wei, J., Hu, H., Huang, Q., Wang, Q., Yang, P., Liang, W., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03145-1 · Cited by 22

AKT signalling is required for ribosomal RNA synthesis and progression of E μ‐Myc B ‐cell lymphoma in vivo

Devlin, J. R., Hannan, K. M., Ng, P. Y., Bywater, M. J., Shortt, J., Cullinane, C. M., McArthur, G. A., Johnstone, R. W., Hannan, R. D., & Pearson, R. B. (2013) · FEBS Journal · doi:10.1111/febs.12135 · Cited by 21

The p53-inducible gene EI24/PIG8 localizes to human chromosome 11q23 and the proximal region of mouse chromosome 9

Gu, Z., Gilbert, D. J., Valentine, V. A., Jenkins, N. A., Copeland, N. G., & Zambetti, G. P. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015620 · Cited by 21

A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility

Christensen, C., Bártková, J., Mistrík, M., Hall, A., Lange, M. K., Ralfkiær, U., Bártek, J., & Guldberg, P. (2014) · Nature Communications · doi:10.1038/ncomms6348 · Cited by 21

Qualitative Network Modeling of the Myc-p53 Control System of Cell Proliferation and Differentiation

Aguda, B. D., Kim, Y., Kim, H. S., Friedman, A., & Fine, H. A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.052 · Cited by 21

Synergistic Interaction of Rnf8 and p53 in the Protection against Genomic Instability and Tumorigenesis

Halaby, M., Hakem, A., Li, L., Ghamrasni, S. E., Venkatesan, S., Hande, M. P., Sanchez, O. H., & Hakem, R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003259 · Cited by 21

Probing the Role of Nascent Helicity in p27 Function as a Cell Cycle Regulator

Otieno, S. B., & Kriwacki, R. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047177 · Cited by 21

Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression

Kim, M., Ju, H., Lim, B., & Kang, C. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs280 · Cited by 21

The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia

Moreno–Miralles, I., Pan, L., Keates‐Baleeiro, J., Goodwin, K. D., Yang, C., Kim, H., Thompson, M. A., Klug, C. A., Cleveland, J. L., & Hiebert, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506855200 · Cited by 21

La3+-Induced Extracellular Signal-Regulated Kinase (ERK) Signaling via a Metal-Sensing Mechanism Linking Proliferation and Apoptosis in NIH 3T3 Cells

Yu, S., Hu, J. H., Yang, X., Wang, K., & Qian, Z. (2006) · Biochemistry · doi:10.1021/bi060895d · Cited by 21

Cancer

Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.007 · Cited by 21

Oncogenes as Novel Targets for Cancer Therapy (Part IV)

Zhang, Z., Li, M., Rayburn, E. R., Hill, D. L., Zhang, R., & Wang, H. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505060-00006 · Cited by 21

Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas

Meléndez, B., Malumbres, M., de Castro, I. P., Santos, J., Pellicer, À., & Fernández‐Piqueras, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.817 · Cited by 21

Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF

Kadaja, L., Laos, S., & Maimets, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207359 · Cited by 21

Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint

Miceli, A. P., Saporita, A. J., & Weber, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06030-11 · Cited by 20

Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism.

Azmi, A. S., Ali, S. S., Banerjee, S., Bao, B., Maitah, M. Y., Padhyé, S., Philip, P. A., Mohammad, R. M., & Sarkar, F. H. (2011) · PubMed Central · Cited by 20

Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis

Zekri, A., Ghaffari, S. H., Yousefi, M., Ghanizadeh-Vesali, S., Mojarrad, M., Alimoghaddam, K., & Ghavamzadeh, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.002 · Cited by 20

p14ARF expression in invasive breast cancers and ductal carcinoma in situ– relationships to p53 and Hdm2

Vestey, S. B., Sen, C., Calder, C. J., Perks, C. M., Pignatelli, M. N., & Winters, Z. (2004) · Breast Cancer Research · doi:10.1186/bcr912 · Cited by 20

The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis

Romeo, M., Hutchison, T., Malu, A., White, A., Kim, J., Gardner, R., Smith, K., Nelson, K., Bergeson, R., McKee, R., et al. (2018) · Virology · doi:10.1016/j.virol.2018.02.010 · Cited by 20

Loss of p14ARF confers resistance to heat shock‐ and oxidative stress‐mediated cell death by upregulating β‐catenin

Damalas, A., Velimezi, G., Kalaitzakis, A., Liontos, M., Papavassiliou, A. G., Gorgoulis, V. G., & Angelidis, C. E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25510 · Cited by 20

Deciphering c-MYC-regulated genes in two distinct tissues

Robson, S. C., Ward, L., Brown, H. K., Turner, H., Hunter, E., Pelengaris, S., & Khan, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-476 · Cited by 20

The p53 Tumor Suppressor Pathway and Cancer

Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20

Id2 Is Dispensable for Myc-Induced Lymphomagenesis

Nilsson, J. A., Nilsson, L. M., Keller, U. B., Yokota, Y., Boyd, K. L., & Cleveland, J. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2133 · Cited by 20

Functional Link Between Myc and the Werner Gene in Tumorigenesis

Grandori, C., Robinson, K. L., Galloway, D. A., & Swisshelm, K. L. (2004) · Cell Cycle · doi:10.4161/cc.3.1.630 · Cited by 20

Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis

Nemajerová, A., Wolff, S., Petrenko, O., & Moll, U. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.074 · Cited by 20

CDK2 Is Required By MYC to Induce Apoptosis

Deb-Basu, D., Aleem, E. A., Kaldis, P., & Felsher, D. W. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2859 · Cited by 20

Regulation of p53-dependent transcription

Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20

Melatonin finely tunes proliferation and senescence in hematopoietic stem cells

Cruciani, S., Garroni, G., Pala, R., Barcessat, A. R. P., Facchin, F., Ventura, C., Fozza, C., & Maioli, M. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151251 · Cited by 19

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, O. J., Weishaupt, H., Zhao, M., Rosén, G., Borgenvik, A., Breinschmid, L., Verbaan, A. D., Richardson, S., Thompson, D., Clifford, S. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36847-9 · Cited by 19

Too big not to fail: emerging evidence for size‐induced senescence

Manohar, S., & Neurohr, G. E. (2023) · FEBS Journal · doi:10.1111/febs.16983 · Cited by 21

Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration

Walker, J. L., Smiley, L. C., Ingram, D. A., & Roman, A. (2010) · Virology · doi:10.1016/j.virol.2010.11.010 · Cited by 20

Malignant Melanoma–a Genetic Overview

Bloethner, S., Scherer, D., Drechsel, M., Hemminki, K., & Kumar, R. (2009) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(09)73167-9 · Cited by 19

Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution

Puccetti, M. V., Fischer, M. A., Arrate, M. P., Boyd, K. L., Duszynski, R. J., Betous, R., Cortez, D., & Eischen, C. M. (2016) · Oncogene · doi:10.1038/onc.2016.408 · Cited by 19

Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models

Vecchio, E., Fiume, G., Correnti, S., Romano, S., Iaccino, E., Mimmi, S., Maisano, D., Nisticò, N., & Quinto, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124265 · Cited by 19

Novel murine B‐cell lymphoma/leukemia model to study BCL2‐driven oncogenesis

Meijerink, J. P. P., Lieshout, E. M. M. V., Beverloo, H. B., van Drunen, E., Mensink, E. J. B. M., Macville, M. V. E., & Pieters, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20822 · Cited by 19

DNA Replication Licensing Factor Minichromosome Maintenance Deficient 5 Rescues p53-Mediated Growth Arrest

Agarwal, M. K., Amin, A. R. M. R., & Agarwal, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2835 · Cited by 19

Intracellular signalling and cancer: complex pathways lead to multiple targets

Bell, H. S., & Ryan, K. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.022 · Cited by 20

Loss of HuR leads to senescence-like cytokine induction in rodent fibroblasts by activating NF-κB

Hashimoto, M., Tsugawa, T., Kawagishi, H., Asai, A., & Sugimoto, M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.07.005 · Cited by 20

A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye

Zheng, Y., Devitt, C. C., Liu, J., Mei, J., & Skapek, S. X. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.05.003 · Cited by 20

Pierce1, a Novel p53 Target Gene Contributing to the Ultraviolet-Induced DNA Damage Response

Sung, Y. H., Kim, H. J., Devkota, S., Roh, J., Lee, J., Rhee, K., Bahk, Y. Y., & Lee, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0031 · Cited by 19

Studies on modulation of the activity of tumor suppressor protein p53

Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19

Oncogene-dependent Tumor Suppression: Using the Dark Side of the Force for Cancer TherapyPreprint

Evan, G. I., CHRISTOPHOROU, M., LAWLOR, E. A., Ringshausen, I., Prescott, J. E., Dansen, T. B., Finch, A. J., Martins, C. P., & Murphy, D. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.054 · Cited by 19

Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma

Harrington, C. T., Sotillo, E., Robert, A., Hayer, K. E., Bogusz, A. M., Psathas, J. N., Yu, D., Taylor, D. M., Dang, C. V., Klein, P. S., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0650-2 · Cited by 19

PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma

Simoni, M., Menegazzi, C., Fracassi, C., Biffi, C. C., Genova, F., Tenace, N. P., Lucianò, R., Raimondi, A., Tacchetti, C., Brugarolas, J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00077-3 · Cited by 18

Mimicking p14ARF Phosphorylation Influences Its Ability to Restrain Cell Proliferation

Vivo, M., Ranieri, M., Sansone, F., Santoriello, C., Calogero, R., Calabrò, V., Pollice, A., & Mantia, G. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053631 · Cited by 19

The TRIP from ULF to ARF

Collado, M., & Serrano, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.015 · Cited by 19

Loss of function tp53 mutations do not accelerate the onset of myc‐induced T‐cell acute lymphoblastic leukaemia in the zebrafish

Gutiérrez, A., Feng, H., Stevenson, K. E., Neuberg, D. S., Calzada, O., Zhou, Y., Langenau, D. M., & Look, A. T. (2014) · British Journal of Haematology · doi:10.1111/bjh.12851 · Cited by 18

The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression

Pan, W., Issaq, S. H., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021625 · Cited by 18

Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events

Parks, T. E. C., Marcellus, K. A., Langill, J., Ravel‐Chapuis, A., Michaud, J., Cowan, K. N., Côté, J., & Jasmin, B. J. (2017) · Scientific Reports · doi:10.1038/srep42342 · Cited by 18

CDK inhibitors for muscle stem cell differentiation and self-renewal

Mohan, A., & Asakura, A. (2017) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.6.65 · Cited by 18

Generation of combined hepatocellular‐cholangiocarcinoma through transdifferentiation and dedifferentiation in p53‐knockout mice

Liu, Y., Bing, X., Yamamoto, M., Goto, M., Ooshio, T., Kamikokura, Y., Tanaka, H., Meng, L., Okada, Y., Mizukami, Y., et al. (2021) · Cancer Science · doi:10.1111/cas.14996 · Cited by 19

Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression

Wakoh, T., Uekawa, N., Terauchi, K., Sugimoto, M., Ishigami, A., Shimada, J., & Maruyama, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.171 · Cited by 18

Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth

Zhang, Y., Yang, H.-Y., Zhang, X.-C., Yang, H., Tsai, M., & Lee, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207918 · Cited by 19

Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells

Wang, X., Liu, X., Xue, L., Zhang, K., Kuo, M.-L., Hu, S., Zhou, B., Ann, D. K., Zhang, S., & Yen, Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.114 · Cited by 18

E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis

Hong, S., Paulson, Q. X., & Johnson, D. G. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5286 · Cited by 19

p19ARFDetermines the Balance between Normal Cell Proliferation Rate and Apoptosis during Mammary Gland Development

Yi, Y., Shepard, A., Kittrell, F. S., Mulac‐Jeričević, B., Medina, D., & Said, T. K. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0785 · Cited by 18

Death‐associated protein 3 regulates cellular senescence through oxidative stress response

Murata, Y., Wakoh, T., Uekawa, N., Sugimoto, M., Asai, A., Miyazaki, T., & Maruyama, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.004 · Cited by 18

Modeling malignant melanoma in mice: pathogenesis and maintenance

Chin, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203106 · Cited by 18

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice

Jamerson, M. H., Johnson, M. D., Korsmeyer, S. J., Furth, P. A., & Dickson, R. B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602137 · Cited by 18

Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF

Lo, D., Zhang, Y., Dai, M.-S., Sun, X.-X., Zeng, S. X., & Lu, H. (2014) · Oncogene · doi:10.1038/onc.2014.103 · Cited by 22

Ei24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation

Sung, Y. H., Jin, Y., Kang, Y., Devkota, S., Lee, J., Roh, J.-I., & Lee, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477570 · Cited by 17

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response

Madapura, H. S., Salamon, D., Wiman, K. G., Laı́n, S., Klein, E., & Nagy, N. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1160975 · Cited by 18

Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression

Ko, T., Sharma, R., & Li, S. (2019) · Oncogene · doi:10.1038/s41388-019-1022-0 · Cited by 18

Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy

Klimovich, B., Mutlu, S., Schneikert, J., Elmshäuser, S., Klimovich, M., Nist, A., Mernberger, M., Timofeev, O. N., & Stiewe, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910255116 · Cited by 17

The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways

Zhao, L., Li, H., Huang, X., Liu, T., Xin, Y., Xiao, Z., Zhao, W., Miao, S., Chen, J., Li, Z., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112360 · Cited by 17

INACTIVATION OF BOTH Rb AND p53 PATHWAYS IN MOUSE LUNG EPITHELIAL CELL LINES

McDoniels-Silvers, A. L., Herzog, C. R., Tyson, F. L., Malkinson, A. M., & You, M. (2001) · Experimental Lung Research · doi:10.1080/019021401300054064 · Cited by 17

The Mitochondrial Apoptosis-Inducing Factor Plays a Role in E2F-1?Induced Apoptosis in Human Colon Cancer Cells

Vorburger, S. A., Pataer, A., Yoshida, K., Liu, Y., Lu, X., Swisher, S. G., & Hunt, K. K. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.05.021 · Cited by 17

Anti-apoptotic MCL-1 Localizes to the Mitochondrial Matrix and Couples Mitochondrial Fusion to Respiration

Perciavalle, R. M. (2012) · doi:10.21007/etd.cghs.2012.0242 · Cited by 17

8‐chloro‐adenosine‐induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites

Zhang, H., Li, W., Yang, S., Li, S., Ni, J., & Jia, H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22033 · Cited by 16

p53 as the main traffic controller of the cell signaling network

Sebastian, S. (2010) · Frontiers in bioscience · doi:10.2741/3669 · Cited by 16

The role of structural disorder in cell cycle regulation, related clinical proteomics, disease development and drug targeting

Tantos, Á., Kalmár, L., & Tompa, P. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1042866 · Cited by 16

Upregulation of Myc promotes the evasion of NK cell‑mediated immunity through suppression of NKG2D ligands in K562 cells

Lee, Y., Heo, W., Son, C., Kang, C., Park, Y.-S., & Bae, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10583 · Cited by 16

Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3

Miki, J., Fujimura, Y., Koseki, H., & Kamijo, T. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01135.x · Cited by 16

Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2

Walczynski, J., Lyons, S., Jones, N., & Breitwieser, W. (2013) · Oncogene · doi:10.1038/onc.2013.28 · Cited by 16

Molecular mechanisms of cellular senescence and immortalization of human cells

Kiyono, T. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.12.1623 · Cited by 16

E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway

Russell, J., Weaks, R. L., Berton, T. R., & Johnson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1209120 · Cited by 17

The tumorigenic characteristics of Lime-Piper betel quid-transformed JB6 cells

Lin, M., Wang, C., Huang, H., Chou, M., & Chou, F. (2004) · Archives of Toxicology · doi:10.1007/s00204-003-0524-1 · Cited by 16

KSHV manipulation of the cell cycle and apoptosis

Moore, P. S. (2007) · Europe PMC (PubMed Central) · Cited by 16

Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells

Geick, A., Redecker, P., Ehrhardt, A., Klocke, R., Paul, D., & Halter, R. (2001) · Transgenic Research · doi:10.1023/a:1013085228119 · Cited by 16

Molecular genetics of acute lymphoblastic leukemia

Ferrando, A. A., Rubnitz, J. E., & Look, A. T. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.011 · Cited by 16

p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53

Magro, P. G., Russo, A. J., Li, W., Banerjee, D., & Bertino, J. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1045 · Cited by 16

Phosphorylation of p53 Serine 18 Upregulates Apoptosis to Suppress Myc-Induced Tumorigenesis

Sluss, H. K., Gannon, H., Coles, A. H., Shen, Q., Eischen, C. M., & Jones, S. N. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0324 · Cited by 16

Emerging molecular networks in Burkitt's lymphoma

Mangani, D., Roberti, A., Rizzolio, F., & Giordano, A. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24358 · Cited by 15

Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts

Masuda, K., Ishikawa, Y., Onoyama, I., Unno, M., de Alborán, I. M., Nakayama, K., & Nakayama, K. (2009) · Oncogene · doi:10.1038/onc.2009.469 · Cited by 15

The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models

Neil, J. C., Gilroy, K. L., Borland, G., Hay, J., Terry, A., & Kilbey, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_16 · Cited by 15

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo

Helmrich, A., Lee, S., O’Brien, P. C., Dörken, B., Lowe, S. W., Schröck, E., & Schmitt, C. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208600 · Cited by 15

Consistent inactivation of p19Arf but not p15Ink4b in murine myeloid cells transformed in vivo by deregulated c-Myc

Haviernik, P., Schmidt, M., Hu, X., & Wolff, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206268 · Cited by 15

Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis

Matsuoka, M., Kurita, M., Sudo, H., Mizumoto, K., Nishimoto, I., & Ogata, E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00080-9 · Cited by 15

HuR Maintains a Replicative Life Span by Repressing the ARF Tumor Suppressor

Kawagishi, H., Hashimoto, M., Nakamura, H., Tsugawa, T., Watanabe, A., Kontoyiannis, D. L., & Sugimoto, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01277-12 · Cited by 15

Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins

Yapindi, L., Bowley, T. Y., Kurtaneck, N., Bergeson, R. L., James, K., Wilbourne, J., Harrod, C. K., Hernandez, B. Y., Emerling, B. E., Yates, C., et al. (2023) · Virology · doi:10.1016/j.virol.2023.05.004 · Cited by 15

Manipulating Myc for reparative regeneration

Ascanelli, C., Dahir, R., & Wilson, C. H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1357589 · Cited by 15

ARF‐dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress

Wang, S., Tian, C., Xing, G., Gao, M., Jiao, W., Xiao, T., Yin, Y., He, F., & Zhang, L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.015 · Cited by 14

Functional Interaction between Type III-Secreted Protein IncA of Chlamydophila psittaci and Human G3BP1

Borth, N., Litsche, K., Franke, C., Sachse, K., Saluz, H. P., & Hänel, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016692 · Cited by 14

Maintaining Low BCR-ABL Signaling Output to Restrict CML Progression and Enable Persistence

Burchert, A. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-013-0196-8 · Cited by 15

p19Arf Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms

Widau, R. C., Zheng, Y., Sung, C. Y., Zelivianskaia, A. S., Roach, L. E., Bachmeyer, K. M., Abramova, T. V., Desgardin, A., Rosner, A., Cunningham, J. M., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06424-11 · Cited by 15

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

Steifensand, F., Gallwas, J. K. S., Bauerschmitz, G. J., & Gründker, C. (2021) · Cells · doi:10.3390/cells10092398 · Cited by 15

ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis

Kotsinas, A., Papanagnou, P., Evangelou, K., Trigas, G. C., Kostourou, V., Townsend, P. A., & Gorgoulis, V. G. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00236 · Cited by 14

Transcriptional activation of the senescence regulator Lsh by E2F1

Niu, J., Chen, T., Han, L., Wang, P., Li, N., & Tong, T. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.03.004 · Cited by 14

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819

Regulation of Myc function by ARF: Checkpoint for Myc-induced oncogenesis

Sarkar, D., & Fisher, P. B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.6.2939 · Cited by 6

Abstract A40: Investigating the functional response of the ARF tumor suppressor to acute p53 loss

Forys, J. T., Kladney, R. D., & Weber, J. D. (2011) · Cancer Research · doi:10.1158/1538-7445.fbcr11-a40

p19ARF directly and differentially controls the functions of c-Myc independently of p53

Qi, Y., Gregory, M. A., Li, Z., Brousal, J. P., West, K. A., & Hann, S. (2004) · Nature · doi:10.1038/nature02958 · Cited by 214

Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc

Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39